Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Vitrectomy for center-involved diabetic macular edema.

Browning DJ, Lee C, Stewart MW, Landers MB 3rd.

Clin Ophthalmol. 2016 Apr 26;10:735-42. doi: 10.2147/OPTH.S104906. eCollection 2016.

2.

Correspondence.

Stewart MW, Landers MB 3rd, Browning DJ, Murata T, Ohji M, Nawrocki J, Chhablani JK.

Retina. 2016 Mar;36(3):e22-3. doi: 10.1097/IAE.0000000000000957. No abstract available.

PMID:
26841212
3.

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.

4.

Vitreous humor thermodynamics during phacoemulsification.

Salcedo-Villanueva G, Kon-Jara V, Harasawa M, Cervantes-Coste G, Ochoa-Contreras D, Morales-Cantón V, Guerrero-Naranjo JL, Quiroz-Mercado H, Landers MB 3rd.

Int Ophthalmol. 2015 Aug;35(4):557-64. doi: 10.1007/s10792-014-9983-z. Epub 2014 Aug 7.

PMID:
25099249
5.

The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479.

6.

Immediate hyphema after intravitreal injections of ranibizumab.

Kon Graversen VA, Meredith T, Landers MB 3rd, Garg S.

Retin Cases Brief Rep. 2013 Summer;7(3):242-4. doi: 10.1097/ICB.0b013e31828eeef8.

PMID:
25391114
7.

Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group.

Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.

8.

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.

9.

Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.

10.

Multimodality diagnostic imaging in a case of sympathetic ophthalmia.

Fleischman D, Say EA, Wright JD, Landers MB.

Ocul Immunol Inflamm. 2012 Aug;20(4):300-2. doi: 10.3109/09273948.2012.682637. Epub 2012 May 17. No abstract available.

PMID:
22594960
11.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

12.

Determination of retinal and vitreous temperature in vitrectomy.

Landers MB 3rd, Watson JS, Ulrich JN, Quiroz-Mercado H.

Retina. 2012 Jan;32(1):172-6. doi: 10.1097/IAE.0b013e31821c3ee0.

PMID:
21878844
13.

The landers trunkless temporary keratoprosthesis.

Watson JS, Tran TT, Landers MB 3rd.

Arch Ophthalmol. 2011 Aug;129(8):1067-9. doi: 10.1001/archophthalmol.2011.189.

PMID:
21825190
14.

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.

15.

Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2011 Jun;151(6):999-1006.e4. doi: 10.1016/j.ajo.2010.11.029. Epub 2011 Mar 10.

16.

Maintaining a watertight globe while operating with a temporary keratoprosthesis.

Watson JS, Tran TT, Porfilio WL, Landers MB 3rd.

Retina. 2011 Jun;31(6):1118-21. doi: 10.1097/IAE.0b013e318203c16e.

PMID:
21394066
17.

The new lens holder for Peyman-Wessels-Landers 132D upright vitrectomy lens.

Kakinoki M, Hirakata A, Landers MB 3rd, Ohji M.

Retina. 2010 Sep;30(8):1316-7. doi: 10.1097/IAE.0b013e3181e9115e. No abstract available.

PMID:
20827144
18.

Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C; Ocular Complications of AIDS Research Group.

Clin Infect Dis. 2010 Oct 15;51(8):947-56. doi: 10.1086/656415.

19.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2010 Nov;117(11):2152-61.e1-2. doi: 10.1016/j.ophtha.2010.03.031. Epub 2010 Jul 29.

20.

The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study.

Velez-Montoya R, Fromow-Guerra J, Burgos O, Landers MB 3rd, Morales-Catón V, Quiroz-Mercado H.

Retina. 2009 Jan;29(1):20-6. doi: 10.1097/IAE.0b013e318186c64e.

PMID:
18784623

Supplemental Content

Loading ...
Support Center